Motus GI is on track to grow its Pure-Vu endoscopy system in 2021, according to CEO Tim Moran. He spoke on four value-creation drivers — reimbursement, product innovation, clinical data and strategic partnerships — in an earnings call transcribed by Seeking Alpha March 16. The company recently reported a $19.3 million net loss in 2020 and a $4.4 million net loss in the fourth quarter, a slight improvement from 2019. Five quotes from Mr. Moran on value-creation drivers and performance: On reimbursement: “In the fourth quarter, we submitted an application to CMS for a new technology add-on payment. This program could provide reimbursement…
Author: Praveen Suthrum
Medical groups spoke about the need for Congress to avert a series of cuts during a briefing on Tuesday sponsored by the American Medical Group Association (AMGA), which represents specialty medical groups. “On heels of public health emergency to be dealt this blow it does feel a little bit like ‘death by a thousand paper cuts,’” said Carol Brockmiller, CEO of Quincy Medical Group, a group of more than 150 doctors, during the briefing. Providers are facing 9.75% in cuts to Medicare reimbursements in the next year. This includes 4% in cuts due to go into effect under the PAYGO…
Your patient tells you she has had a colonoscopy. Can you be sure she’s correct? If a recent study of patients in New York City is representative, the answer is probably not. An inspection of patient records at Lenox Hill Hospital found documentation of self-reported colonoscopy in only 15% of cases, according to David Kadosh, MD, of Lenox Hill, part of the Northwell Health system, in a poster presented at the virtual 2020 meeting of the American College of Gastroenterology (abstract P2561). “Screening for colorectal cancer is often self-reported from the patient and there are several obstacles to obtaining and…
The tumor necrosis factor (TNF) inhibitor infliximab (Remicade) was associated with attenuated serological responses to SARS-CoV-2 infection in patients with inflammatory bowel disease (IBD), a multicenter study from the U.K. found. These responses were further attenuated in those who also received immunomodulators, said Tariq Ahmad, MD, of the Royal Devon and Exeter NHS Foundation Trust in England, and colleagues. Compared with vedolizumab (Entyvio), infliximab was independently tied to lower seropositivity (OR 0.66, 95% CI 0.51-0.87, P=0.0027), as was concomitant immunomodulator use (OR 0.70, 95% CI 0.53-0.92, P=0.012), they reported online in Gut.
While hosting the live radio broadcast “Chiefs Rounds” on Sirius XM Doctor Radio, I had the privilege to have Gbenga Ogedegbe, MD, MPH, as my guest. Ogedegbe is a friend and colleague who was recently appointed to run a new endeavor at NYU Langone Health called the Institute for Excellence in Health Equity. While discussing the horrific fatalities and disparities seen during the COVID 19 Pandemic, Gbenga said something that is well known to health equity researchers: “When it comes to health outcomes and life expectancy, your ZIP code is more important than your genetic code”. This was the case for COVID…
I’m David Kerr, professor of cancer medicine from University of Oxford in England. I have had a lifelong professional interest in the biology and treatment of colorectal cancer. A nice paper popped up recently in The Lancet Oncology, looking at the impact of colorectal cancer screening. I’ve said this many times before, but as I’ve become older, more mature (one might argue), and wiser (possibly), I’ve become interested more in the concept of prevention rather than cure, given the relatively sparse armamentarium of drugs that we have to manage colorectal cancer. This excellent paper reports an outstanding European-wide study of…
An ideal bowel preparation should have many attributes, including the ability to reliably empty the colon in a rapid fashion, without causing any gross or histologic alteration of colonic mucosa, shifts in fluids and electrolytes, or patient discomfort, and it should be relatively inexpensive. This article discusses quality measures for bowel preparation, as well as various tools to measure the quality of bowel preparation and ways to improve it. This review is meant to provide gastroenterologists and endoscopists with strategies and best practices to get their patients to optimize bowel preparation.
After more than two decades of helping freestanding, single-specialty endoscopic ASCs thrive across the U.S., Physicians Endoscopy is entering the next phase of growth and development. The company, which has partnerships with 60 gastroenterology surgery centers and more than 600 gastroenterologists nationwide, is expanding its services to include practice management and development. The company has rebranded to PE GI Solutions to reflect its current business strategy and services added over the years. “We are moving forward and beyond from being a GI provider to ASCs. The rebrand takes us closer to the patients by being involved in the practice side…
Here are 10 physicians who specialize in gastroenterology: Hasan Ali, MD. Delaware Center for Digestive Care (Newark). Dr. Ali earned his medical degree from Gandhi Medical College in India. He completed his residency at Nassau University Medical Center in East Meadow, N.Y., and his fellowship at Albany (N.Y.) Medical College. He was previously an assistant professor at Thomas Jefferson University Hospital in Philadelphia, where he was named “Outstanding Teacher of the Year” in 1998. He was also named a physician ambassador at ChristianaCare Wilmington (Del.) Hospital.
According to the World Health Organization’s data in 2020, colorectal cancer is the third most common cancer after breast cancer and lung cancer, and is ranked second in cancer-related deaths after lung cancer. Approximately 1.9 million people were diagnosed and more than 900,000 patients died of colorectal cancer worldwide. The most common regions with the highest incidence and mortality rates include Europe, Australia, New Zealand, North America, and Eastern Asia. Once diagnosed at an early stage, colorectal cancer has an impressive survival rate of over 90% at 5 years. However, when it is detected at a late stage that the…